Nek1 phosphorylates von Hippel-Lindau tumor suppressor to promote its proteasomal degradation and ciliary destabilization

Cell Cycle

Volumn 12, Issue 1, 2013, Pages 166-171

  Patil, Mallikarjun ^a   Pabla, Navjotsingh ^a,b   Huang, Shuang ^a   Dong, Zheng ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cilium; Hypoxia inducible factor; Nek1; Phosphorylation; VHL

Indexed keywords

BORTEZOMIB; HYPOXIA INDUCIBLE FACTOR; NOCODAZOLE; PROTEASOME; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE NEK1; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME SUBSTRATE; EUKARYOTIC FLAGELLUM; GENE MUTATION; GENE OVEREXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

EID: 84872324536     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23053     Document Type: Article

References (31)

1. Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol 2004; 22:4991-5004; PMID:15611513; http://dx.doi.org/10.1200/JCO.2004.05. 061.
2. Kaelin WG. Von Hippel-Lindau disease. Annu Rev Pathol 2007; 2:145-73; PMID:18039096; http://dx.doi.org/10.1146/annurev.pathol.2.010506.092049.
3. Haase VH. The VHL tumor suppressor in development and disease: functional studies in mice by conditional gene targeting. Semin Cell Dev Biol 2005; 16:564-74; PMID:15908240; http://dx.doi.org/10.1016/j.semcdb.2005.03.006.
4. Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007; 2007:cm8; PMID:17925579; http://dx.doi.org/10.1126/stke.4072007cm8.
5. Kaelin WG Jr., Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30:393-402; PMID:18498744; http://dx.doi.org/10.1016/j.molcel.2008.04.009.
6. Haase VH. The VHL tumor suppressor: master regulator of HIF. Curr Pharm Des 2009; 15:3895-903; PMID:19671042; http://dx.doi.org/10.2174/ 138161209789649394.
7. Li M, Kim WY. Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL. J Cell Mol Med 2011; 15:187-95; PMID:21155973; http://dx.doi.org/10.1111/j.1582-4934.2010.01238.x.
8. Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, et al. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell 1998; 1:959-68; PMID:9651579; http://dx.doi.org/10.1016/S1097-2765(00)80096-9.
9. Tang N, Mack F, Haase VH, Simon MC, Johnson RS. pVHL function is essential for endothelial extracellular matrix deposition. Mol Cell Biol 2006; 26:2519-30; PMID:16537898; http://dx.doi.org/10.1128/MCB.26.7.2519-2530.2006.
10. Hergovich A, Lisztwan J, Barry R, Ballschmieter P, Krek W. Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol 2003; 5:64-70; PMID:12510195; http://dx.doi.org/10.1038/ncb899.
11. Thoma CR, Frew IJ, Hoerner CR, Montani M, Moch H, Krek W. pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat Cell Biol 2007; 9:588-95; PMID:17450132; http://dx.doi.org/10.1038/ncb1579.
12. O'regan L, Blot J, Fry AM. Mitotic regulation by NIMA-related kinases. Cell Div 2007; 2:25; PMID:17727698; http://dx.doi.org/10.1186/1747-1028-2-25.
13. White MC, Quarmby LM. The NIMA-family kinase, Nek1 affects the stability of centrosomes and ciliogenesis. BMC Cell Biol 2008; 9:29; PMID:18533026; http://dx.doi.org/10.1186/1471-2121-9-29.
14. Moniz L, Dutt P, Haider N, Stambolic V. Nek family of kinases in cell cycle, checkpoint control and cancer. Cell Div 2011; 6:18; PMID:22040655; http://dx.doi.org/10.1186/1747-1028-6-18.
15. Natoli TA, Gareski TC, Dackowski WR, Smith L, Bukanov NO, Russo RJ, et al. Pkd1 and Nek8 mutations affect cell-cell adhesion and cilia in cysts formed in kidney organ cultures. Am J Physiol Renal Physiol 2008; 294:F73-83; PMID:17928412; http://dx.doi.org/10.1152/ajprenal.00362.2007.
16. Chen Y, Chen PL, Chen CF, Jiang X, Riley DJ. Never-in-mitosis related kinase 1 functions in DNA damage response and checkpoint control. Cell Cycle 2008; 7:3194-201; PMID:18843199; http://dx.doi.org/10.4161/cc.7.20.6815.
17. Chen Y, Chen CF, Riley DJ, Chen PL. Nek1 kinase functions in DNA damage response and checkpoint control through a pathway independent of ATM and ATR. Cell Cycle 2011; 10:655-63; PMID:21301226; http://dx.doi.org/10.4161/cc.10.4. 14814.
18. Upadhya P, Birkenmeier EH, Birkenmeier CS, Barker JE. Mutations in a NIMA-related kinase gene, Nek1, cause pleiotropic effects including a progressive polycystic kidney disease in mice. Proc Natl Acad Sci USA 2000; 97:217-21; PMID:10618398; http://dx.doi.org/10.1073/pnas.97.1.217.
19. Thiel C, Kessler K, Giessl A, Dimmler A, Shalev SA, von der Haar S, et al. NEK1 mutations cause short-rib polydactyly syndrome type majewski. Am J Hum Genet 2011; 88:106-14; PMID:21211617; http://dx.doi.org/10.1016/j.ajhg.2010.12. 004.
20. Shalom O, Shalva N, Altschuler Y, Motro B. The mammalian Nek1 kinase is involved in primary cilium formation. FEBS Lett 2008; 582:1465-70; PMID:18387364; http://dx.doi.org/10.1016/j.febslet.2008.03.036.
21. Schoenfeld AR, Davidowitz EJ, Burk RD. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Proc Natl Acad Sci USA 2000; 97:8507-12; PMID:10900011; http://dx.doi.org/10.1073/pnas.97.15. 8507.
22. Mohan S, Burk RD. von Hippel-Lindau protein complex is regulated by cell density. Oncogene 2003; 22:5270-80; PMID:12917628; http://dx.doi.org/10.1038/sj. onc.1206592.
23. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271-5; PMID:10353251; http://dx.doi.org/10.1038/20459.
24. Esteban MA, Harten SK, Tran MG, Maxwell PH. Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein. J Am Soc Nephrol 2006; 17:1801-6; PMID:16775032; http://dx.doi.org/10. 1681/ASN.2006020181.
25. Ampofo E, Kietzmann T, Zimmer A, Jakupovic M, Montenarh M, Götz C. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription. Int J Biochem Cell Biol 2010; 42:1729-35; PMID:20637892; http://dx.doi.org/10.1016/j.biocel.2010.07.008.
26. Roe JS, Kim HR, Hwang IY, Ha NC, Kim ST, Cho EJ, et al. Phosphorylation of von Hippel-Lindau protein by checkpoint kinase 2 regulates p53 transactivation. Cell Cycle 2011; 10:3920-8; PMID:22071692; http://dx.doi.org/ 10.4161/cc.10.22.18096.
27. Lolkema MP, Gervais ML, Snijckers CM, Hill RP, Giles RH, Voest EE, et al. Tumor suppression by the von Hippel-Lindau protein requires phosphorylation of the acidic domain. J Biol Chem 2005; 280:22205-11; PMID:15824109; http://dx.doi.org/10.1074/jbc.M503220200.
28. Hergovich A, Lisztwan J, Thoma CR, Wirbelauer C, Barry RE, Krek W. Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. Mol Cell Biol 2006; 26:5784-96; PMID:16847331; http://dx.doi.org/10.1128/MCB.00232-06.
29. Jiang M, Liu K, Luo J, Dong Z. Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol 2010; 176:1181-92; PMID:20075199; http://dx.doi.org/10.2353/ajpath.2010.090594.
30. Pabla N, Ma Z, McIlhatton MA, Fishel R, Dong Z. hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis. J Biol Chem 2011; 286:10411-8; PMID:21285353; http://dx.doi.org/10.1074/jbc.M110.210989.
31. Plotnikova OV, Pugacheva EN, Golemis EA. Primary cilia and the cell cycle. Methods Cell Biol 2009; 94:137-60; PMID:20362089; http://dx.doi.org/10. 1016/S0091-679X(08)94007-3.